November and December Deadlines for Small Business Cancer Technology Grant Funding Opportunities

Full FOA: Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (PAR-13-327)
Upcoming Receipt Dates: November 4, 2013; May 28, 2014

The SBIR-IMAT funding opportunity is aimed at accelerating the development and commercialization of highly innovative technologies that improve molecular and/or cellular analysis of cancer with a significant likelihood for either overcoming persistent challenges or obstacles or opening entirely new fields for cancer research or clinical care. This Program Announcement complements the goals of the NCI’s Innovative Molecular Analysis Technologies (IMAT) Program by facilitating a path towards technology commercialization. Prior participation in the IMAT Program is not required for eligibility for this FOA. Applications are expected to indicate the significant attributes and advantages of the proposed technology over currently available technologies and conventional approaches.

A non-exclusive list of product examples relevant to this funding opportunity are available at: http://sbir.cancer.gov/funding/technology/.

Additional Resources Available
To learn more, please click here to download slides from an SBIR-IMAT pre-application webinar. An audio recording and transcript from the webinar are also available for download.

Funding is available to support small businesses working across a wide range of cancer-related research topic areas through the NIH SBIR & STTR Omnibus Solicitations, investigator-initiated grant funding opportunities. The next deadline to submit applications is December 5, 2013.

SBIR Program
PA-13-234, Re-issue PHS 2013-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])

STTR Program
PA-13-235, Re-issue PHS 2013-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])

The 2013 Omnibus Solicitations expand eligibility and impact the application process, so please read the solicitations carefully.

• Small business concerns that are majority-owned by multiple venture capital operating companies (VCOCs), hedge funds and/or private equity firms are eligible to apply to the NIH SBIR program and compete for up to 25% of NIH’s SBIR set-aside.
• All applicants are required to register at the SBA Company Registry prior to application submission and attach proof of registration. See below for the full list of registration requirements for submitting SBIR/STTR applications to HHS.

The NCI SBIR & STTR Programs have grant funding opportunities available in a wide range of cancer-related topic areas to help small businesses advance their research concepts towards commercialization. The grants below share the deadline of December 5, 2013. Don’t miss your chance to apply!

SBIR Program

• PA-12-196, Innovative Health Information Technology for Broad Adoption by Healthcare Systems and Consumers (SBIR R44)
  For more details and examples of applicable projects, click here.
• PA-13-140, Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR R43/R44)

For a complete listing of funding opportunities from the NCI SBIR & STTR Programs, please click here.

If you are considering applying for an SBIR/STTR award, check that your registrations are all completed.

Applicant organizations must complete and maintain the following registrations as described in the SF 424 (R&R) Application Guide prior to submitting an application to be eligible to apply for or receive an award. Registration can take six weeks or more, so applicants should begin the registration process as soon as possible.

• Dun and Bradstreet Universal Numbering System (DUNS)
• System for Award Management (SAM) (formerly CCR)
• eRA Commons
• Grants.gov
• SBA Company Registry – New requirement since 1/28/13.

If you have difficulties with the submission process, please contact the eRA Commons helpdesk: Toll-free: 1-866-504-9552; Email: commons@od.nih.gov.

• The NIH Niche Assessment Program is a nationwide program that provides free comprehensive market analysis reports for eligible SBIR and STTR Phase I awardees funded in fiscal years 2013 and 2014, which can help jump start commercialization efforts. Applications for the Niche Assessment Program are accepted on a “first-come, first-served” basis until all slots are filled. Please click here to learn more about the Niche Assessment Program, including eligibility and how to apply.